Arrowhead Pharmaceuticals, Inc. (ARWR) vs Bruker Corporation (BRKR)
A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Bruker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARWR
Arrowhead Pharmaceuticals, Inc.
$62.15HealthcareDelayed quote: Oct 6, 2026, 9:35 AM EDT
BRKR
Bruker Corporation
$65.69HealthcareDelayed quote: Oct 6, 2026, 9:35 AM EDT
Total return — ARWR vs BRKR
growth of $100 · dividends reinvested · last 10yARWR +755.3% (+23.9%/yr)BRKR +196.6% (+11.5%/yr)ARWR compounded faster over this window
ARWR BRKR
ARWR vs BRKR: by the numbers
- •BRKR is the larger company ($10.00B vs $8.75B market cap).
- •Both run net losses; BRKR's is the smaller (-2.03% vs -47.79% net margin).
- •ARWR grew revenue faster over the past five years (44.14% vs 9.10% CAGR).
- •BRKR pays a dividend (0.23% yield), while ARWR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ARWR | BRKR |
|---|---|---|
| Forward P/E | N/A | 30.96 |
| P/S ratio | 13.07 | 2.86 |
| P/B ratio | 18.80 | 4.17 |
| EV / EBITDA | N/A | 32.89 |
| FCF yield | N/A | 0.94% |
Profitability
| Metric | ARWR | BRKR |
|---|---|---|
| Gross margin | 100.00% | 46.69% |
| Operating margin | 11.86% | 3.61% |
| Net margin | -47.79% | -2.03% |
| ROE | -68.73% | -2.97% |
| ROIC | -12.12% | 2.56% |
Dividends
| Metric | ARWR | BRKR |
|---|---|---|
| Dividend yield | N/A | 0.23% |
Growth (annualized)
| Metric | ARWR | BRKR |
|---|---|---|
| Revenue CAGR (5Y) | 44.14% | 9.10% |
| FCF CAGR (5Y) | N/A | -21.33% |
| Total return CAGR (5Y) | 0.75% | -3.42% |
Frequently asked
- Which has grown faster, ARWR or BRKR?
- Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus BRKR at 9.10%.
- Does ARWR or BRKR pay a bigger dividend?
- BRKR pays a dividend (0.23% yield), while ARWR has no payments in the available dividend history.
- How have ARWR and BRKR total returns compared?
- Over the past 10 years, ARWR delivered 23.56% and BRKR delivered 11.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bruker dividend yieldArrowhead Pharmaceuticals ROEBruker ROEArrowhead Pharmaceuticals operating marginBruker operating marginArrowhead Pharmaceuticals revenue growthBruker revenue growthArrowhead Pharmaceuticals free cash flowBruker free cash flow
Arrowhead Pharmaceuticals & Bruker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.